[ Price : $8.95]
CDER releases a new policy procedure for handling reviews of grouped chemistry, manufacturing and controls supplements.[ Price : $8.95]
FDA rejects a petition submitted by Natural Resources Defense Council that sought the market withdrawal of products containing lin...[ Price : $8.95]
FDA accepts for review a MAP Pharmaceuticals NDA resubmission for Levadex (dihydroergotamine) inhalation aerosol for treating migr...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance, The Content of Investigational Device Exemption (IDE) and Premarket Approval (PM...[ Price : $8.95]
FDA grants OxiGene an orphan drug designation for OXi4503 for treating acute myelogenous leukemia.[ Price : $8.95]
FDA releases the FDA-483 from a New England District Office 2012 inspection at Alaunus Pharmaceuticals, associated with New Englan...[ Price : $8.95]
Federal Register Notice: FDA plans a pubic hearing 12/12-13 to discuss microbial contamination of patient preoperative skin prepar...[ Price : $8.95]
CDERs Office of Prescription Drug Promotion notifies Alcon that a professional sales aid for its Patanase overstates the drugs eff...